State of the Art – Primärprävention des Mammakarzinoms

Literatur
1 Bevers TB et al. Breast Cancer Risk Reduction. J Natl Compr Canc Netw 2010; 8: 1112-1146
2 Tamoxifen for Prevention of Breast Cancer. J Natl Cancer Inst 1998; 90: 1371-1388
3 Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005; 97: 1652-1662
4 Powles TJ et al. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 2007; 99: 283-290
5 Ropka ME et al. Patient decisions about breast cancer chemoprevention. J Clin Oncol 2010; 28: 3090-3095
6 Cummings SR et al. The Eff ect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women. JAMA 1999; 281: 2189-2197
7 Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 2004; 96: 1751-1761
8 Vogel VG et al. Effects of Tamoxifen vs Raloxifene on the Risk of developing Invasive Breast Cancer and other Disease Outcomes. JAMA 2006; 295: 2727-2741
9 Vogel VG et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res 2010; 3: 696-706
10 Freedman AN et al. Benefit / Risk Assessment for Breast Cancer Chemoprevention with Raloxifene or Tamoxifen for Women Age 50 Years or older. J Clin Oncol 2011; 29: 2327-2333
11 Bushnell CD, Goldstein LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a metaanalysis. Neurology 2004; 63: 1230-1233
12 Braithwaite RS et al. Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med 2003; 18: 937-947
13 . Exemestane for breast cancer prevention in postmenopausal women. N Engl J Med 2011; 364: 2381-2391
14 Pollak M. Metformin and other Biguanides in Oncology. Cancer Prev Res 2010; 3: 1060-1065
15 Metformin associated with Lower Cancer Mortality in Type 2 Diabetes. Diabetes Care 2010; 33: 322-326 Engl J Med 1999; 340: 1837–1839
Weiterführende Literatur bei den Autoren .